These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1924991)

  • 21. Epidemiology of IgA Nephropathy: A Global Perspective.
    Schena FP; Nistor I
    Semin Nephrol; 2018 Sep; 38(5):435-442. PubMed ID: 30177015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical audit of the use of renal biopsy in the management of isolated microscopic hematuria.
    McGregor DO; Lynn KL; Bailey RR; Robson RA; Gardner J
    Clin Nephrol; 1998 Jun; 49(6):345-8. PubMed ID: 9696429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgA nephropathy in teaching hospitals of Dhaka.
    Sharmin F; Khan BR; Rahman M; Rashid HU; Islam B; Kamal M; Barua AR; Chowdhury MA; Mohsin AU; Ahmed S
    Bangladesh Med Res Counc Bull; 1997 Apr; 23(1):25-9. PubMed ID: 9363674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective analysis of the natural history of primary IgA nephropathy worldwide.
    Schena FP
    Am J Med; 1990 Aug; 89(2):209-15. PubMed ID: 2200265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histological differences in new-onset IgA nephropathy between children and adults.
    Ikezumi Y; Suzuki T; Imai N; Ueno M; Narita I; Kawachi H; Shimizu F; Nikolic-Paterson DJ; Uchiyama M
    Nephrol Dial Transplant; 2006 Dec; 21(12):3466-74. PubMed ID: 16935895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The level of serum secretory IgA of patients with IgA nephropathy is elevated and associated with pathological phenotypes.
    Zhang JJ; Xu LX; Liu G; Zhao MH; Wang HY
    Nephrol Dial Transplant; 2008 Jan; 23(1):207-12. PubMed ID: 17938148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Useful indicators for performing renal biopsy in adult patients with isolated microscopic haematuria.
    Shen P; He L; Jiang Y; Wang C; Chen M
    Int J Clin Pract; 2007 May; 61(5):789-94. PubMed ID: 17362478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of interleukin-10 gene G-1082A polymorphism on recurrent IgA nephropathy.
    Bantis C; Heering PJ; Aker S; Schwandt C; Grabensee B; Ivens K
    J Nephrol; 2008; 21(6):941-6. PubMed ID: 19034880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Berger's disease in children: its form of presentation, pathological anatomy and evolution in 22 cases].
    Cabot Dalmau A; Callis L; Lara E; Carreras M
    An Esp Pediatr; 1993 Sep; 39(3):227-34. PubMed ID: 8250437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Berger's disease in children. Natural history and outcome.
    Lévy M; Gonzalez-Burchard G; Broyer M; Dommergues JP; Foulard M; Sorez JP; Habib R
    Medicine (Baltimore); 1985 May; 64(3):157-80. PubMed ID: 3887094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.
    Roos A; Rastaldi MP; Calvaresi N; Oortwijn BD; Schlagwein N; van Gijlswijk-Janssen DJ; Stahl GL; Matsushita M; Fujita T; van Kooten C; Daha MR
    J Am Soc Nephrol; 2006 Jun; 17(6):1724-34. PubMed ID: 16687629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A new etiology of episcleritis: nephropathies with IgA and/or isolated C3 deposits].
    Sirbat D; Saudax E; Hurault de Ligny B; Bene MC; Raspiller A
    J Fr Ophtalmol; 1983; 6(11):921-5. PubMed ID: 6368661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical significance of IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger's disease).
    Sinico RA; Fornasieri A; Maldifassi P; Colasanti G; D'Amico G
    Clin Nephrol; 1988 Oct; 30(4):182-6. PubMed ID: 3214964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New immunopathogenic aspects of IgA nephropathy].
    Hernando L; González-Cabrero J; García-Hoyo R; Hernando P; Egido J
    Bull Acad Natl Med; 1990 May; 174(5):549-59. PubMed ID: 2249143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgA nephropathy: the presence of familial disease does not confer an increased risk for progression.
    Izzi C; Ravani P; Torres D; Prati E; Viola BF; Guerini S; Foramitti M; Frascà G; Amoroso A; Ghiggeri GM; Schena FP; Scolari F
    Am J Kidney Dis; 2006 May; 47(5):761-9. PubMed ID: 16632014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical and pathological features in Venezuelan children with IgA nephropathy].
    Coronel V; Mora-Orta S; Domínguez L; Corado J; Zibaoui PI; Bethencourt S; Weffer M; Pinto JA; Lara E; Orta N
    Invest Clin; 2007 Jun; 48(2):167-74. PubMed ID: 17598640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Favorable outcome of renal transplantation in patients with IgA nephropathy.
    Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF
    Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Berger's disease or primary IgA nephropathy in children].
    Renoult E; Cochat P; Jonon B; Kessler M
    Pediatrie; 1989; 44(5):365-74. PubMed ID: 2812962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
    Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Eto T; Nakao H
    Ren Fail; 2005; 27(1):45-52. PubMed ID: 15717634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current therapy for IgA nephropathy.
    Floege J; Eitner F
    J Am Soc Nephrol; 2011 Oct; 22(10):1785-94. PubMed ID: 21903997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.